Abstract:Objective:To investigate whether spatial memory impairment occurred in mice with chronic neuropathic pain and to investigate transcriptome changes in their hippocampus.Methods:A total of 24 male C57BL/6 mice were divided into two groups according to the random number table method ( n=12): a Sham group and a chronic constrictive injury of sciatic nerve (CCI) group. The paw withdrawal mechanical threshold (PWMT) of each mouse was measured by Von Frey filament test before operation, and 7 days and 28 days after operation. The open-field test was used to detect motor ability and anxiety of the mice 7 days and 28 days after operation. The spatial memory of the mice was detected by the spatial position recognition test. Fresh hippocampal tissue was collected 28 days after operation for transcriptome sequencing to detect gene expression differences between the two groups. Real-time fluorescent quantitative polymerase chain reaction (RT-qPCR) was used to verify the gene expression of fibromodulin (FMOD), bone morphogenetic protein 7 (Bmp7), prostaglandin D2 synthase (PTGDS), and aldehyde dehydrogenase 1 family member A2 (Aldh1a2). Results:Compared with the Sham group, mice in the CCI group presented significantly decreased PWMT on the hind foot of the injured side 7 days ( t=6.01, P<0.001) and 28 days ( t=4.49, P<0.001) after operation. There were no significant differences in movement and anxiety between the two groups 7 and 28 days after surgery (movement distance: 7 days after surgery, t=0.25, P=0.962, and 28 days after surgery, t=0.32, P=0.939; time in center of the open field: 7 days after surgery, t=1.16, P=0.439, 28 days after surgery, t=0.34, P=0.931). There was no statistical difference in spatial memory between the two groups 7 days after surgery ( t=2.00, P=0.101), while the spatial memory of the CCI group was significantly lower than that of the Sham group 28 days after surgery ( t=2.93, P=0.011). Transcriptome sequencing results indicated the presence of a large number of differentially expressed genes (DEGs) in the hippocampus of the two groups. RT-qPCR showed that compared with that in the Sham group, the gene expression of FMOD ( t=8.07, P<0.001), Bmp7 ( t=4.81, P=0.003), PTGDS ( t=4.07, P=0.007) and Aldh1a2 ( t=7.93, P<0.001) in the hippocampus of mice in the CCI group decreased. Conclusions:Mice with chronic neuropathic pain may show spatial memory impairment, and the transcriptome of hippocampal tissue significantly changes.

<TITLE>THE EXPRESSION OF NR2B MRNA IN THE ANTERIOR CINGULATE CORTEX AND L_(4-6) SPINAL CORD IN THE BONE CANCER PAIN MICE

Expression of NR2B in the Spinal Dorsal Horn and Dorsal Root Ganglia in Mice with Bone Cancer Pain

THE EXPRESSION OF NR1 AND NOS IN THE SPINAL DORSAL HORN IN A BONE CANCER PAIN MODEL IN MICE

Pain Behavior and the Expression of Phosphorylated Camp Response Element Binding Protein and Brain-Derived Neurotrophic Factor in Dorsal Horn of Spinal Cord in a Mouse Model of Bone Cancer Pain

Relationship Between Spinal Neuronal Microrna 212 and Phosphorylation of CREB in a Mouse Model of Bone Cancer Pain

Expression changes of metabotropic glutamate receptor 3 and 5 in spinal cord in a mouse model of bone cancer pain

Temporal Changes of Spinal Transcriptomic Profiles in Mice With Spinal Nerve Ligation.

Participation of spinal CaMKII-NR2B signal pathway in the development of bone cancer pain in mice

Changes in the Expression of CREB-regulated Transcription Coactivator 1 in Spinal Cord in Mouse Model of Bone Cancer Pain

Effects of Repeated Intrathecally KIF17 Antisense Oligodeoxynucleotide on the Expression of Mlin10 and NR2B in Spinal Cord in a Mouse Model of Bone Cancer Pain

Effect of Intrathecal Injection of Ifenprodil on the Expression of 2B Subunit Mrna of NMDA Receptor in Spinal Cord in a Mouse Model of Bone Cancer Pain

Role of Spinal Neuronal Mas-related Gene Receptor C in Maintenance of Bone Cancer Pain in Mice

The Role of N‐methyl‐d‐aspartate Receptor Subunit NR2B in Spinal Cord in Cancer Pain

Role of Spinal Neuronal Microrna-132 in a Mouse Model of Bone Cancer Pain

Effects of Repeated Intrathecal CREB Antisense Oligodeoxynucleotide on the Expression of NR2A in Spinal Cord in a Mouse Model of Neuropathic Pain

The role of neuronal nitric oxide synthase in the development of bone cancer pain

Changes in protein expression and distribution of spinal CCR2 in a rat model of bone cancer pain.

Expression of spinal PD-L1 in bone cancer pain model mice and its effect on pain behaviors

Experimental Investigation of CT and Pain Behavioral Charateristics in Bone Cancer Pain Mice

Spatial memory impairment and its transcriptomic profile in the hippocampus of chronic neuropathic pain mice

Expression of IGF-1 in serum and phosphorylated IGF-1 receptor in spinal cord in mouse model of bone cancer pain